4
Changes in Ownership
Vistagen Therapeutics, Inc. Filed Acc 0002069951-26-000004
Options or other derivatives
- Chief Corp Development Officer acquired 75,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cote Elissa S. Chief Corp Development Officer | 2026-04-07 | Grant or award · Incentive Stock Option (right to buy) | +75,000 | 75,000 | D: show line 1 in the form |
Loading xslF345X06/edgardoc.xml…